Latest News
|
More Articles...
- Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
- Adagio Medical Announces First Patient Enrollment in its iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial Fibrillation English
- Affera Announces World's First Successful Focal Pulsed Field Ablation in Patients
- AliveCor Receives Approval to Launch KardiaMobile in Mexico
- AltaThera Pharmaceuticals Announces FDA Approval for New Indications of Sotalol IV: A New and Faster Way to Initiate Sotalol Therapy for Atrial Fibrillation (AFib) Patients
- Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients with Multiple Types of Factor Xa Inhibitor-Related Bleeds
- Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model
- The Cardiac Risk of Chloroquine in Unapproved Indications
- Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine
- FDA approves first generics of Eliquis
|
|